Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 September 2018 Photo Anja Aucamp
Health forum celebrates 50 years of research
Throughout the years many renowned researchers shared their work via the Faculty Research Forum in the UFS Faculty of Health Sciences.

Fifty years ago, visionaries in healthcare established a research forum. Throughout the years, many renowned researchers shared their work via this platform. On 30 and 31 August 2018, the Faculty Research Forum in the Faculty of Health Sciences at the University of the Free State (UFS) hosted their annual event, and celebrated the forum’s 50th anniversary. The programme was characterised by high-quality presentations covering a range of relevant topics, with exhibitors displaying current and innovative technology in the health sciences field. 

On the shoulders of giants

According to the Faculty of Health Sciences Dean, Prof Gert van Zyl, the Faculty Research Forum is a highlight on their calendar. “We owe all our gratitude and appreciation to the founders of the forum, as well as 50 years of researchers who share their research with us each year.” This year was no exception, with interesting and relevant presentations. Evaluations committees comprising external and faculty adjudicators awarded prizes to research articles and student presentations. The level of work showcased once again proved that health science research on campus is alive and well – contributing to the study field. 

Small success

During the FP Retief Lecture, keynote speaker Prof Tahir Pillay shared his passion for new diagnostic probes for laboratory medicine using nanobodies and next generation technology. Prof Pillay is Chief Specialist, Professor and Head of the Department of Chemical Pathology at the University of Pretoria. He is also involved with the National Health Laboratory service, Steve Biko Academic Hospital and the Director of the Division of Clinical Pathology and Clinical Pathology training programme. 

A captive audience appreciated his explanation of what alpacas, llamas, and sharks have in common. These animals have small, single-chain, stable antibodies, significantly improving the possibilities in the field of antibody technology – a chance discovery with far-reaching impacts. 

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept